Gsa Capital Partners LLP Lantheus Holdings, Inc. Transaction History

Gsa Capital Partners LLP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$47.76 - $82.86 $310,105 - $538,009	6,493 New	6,493 $536,000
Q2 2022 Aug 09, 2022	SELL	$55.54 - $72.65 $216,494 - $283,189	-3,898 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$24.28 - $56.64 $94,643 - $220,782	3,898 New	3,898 $216,000
Q3 2019 Nov 12, 2019	SELL	$21.01 - $28.94 $368,914 - $508,157	-17,559 Closed	0 $0
Q2 2019 Aug 06, 2019	SELL	$23.33 - $28.3 $59,281 - $71,910	-2,541 Reduced 12.64%	17,559 $497,000
Q1 2019 May 15, 2019	BUY	$14.93 - $25.1 $107,749 - $181,146	7,217 Added 56.02%	20,100 $492,000
Q4 2018 Feb 12, 2019	BUY	$12.68 - $19.01 $163,356 - $244,905	12,883 New	12,883 $202,000
Q3 2018 Nov 13, 2018	SELL	$13.1 - $16.35 $457,438 - $570,925	-34,919 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$13.65 - $18.7 $166,338 - $227,878	12,186 Added 53.6%	34,919 $508,000
Q1 2018 May 11, 2018	BUY	$14.85 - $24.3 $337,585 - $552,411	22,733 New	22,733 $361,000

538

68.4M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.7B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.